FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/084702 [Registered on: 13/04/2025] Trial Registered Prospectively
Last Modified On: 09/04/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Ayurveda
Yoga & Naturopathy 
Study Design  Single Arm Study 
Public Title of Study   Studying the role of the AIWeLL™ Health Program on Individual Well-Being 
Scientific Title of Study   To Evaluate the Effectiveness of a Whole-System Medicine Approach-Based AIWeLL™ Protocol on Well-Being: A Single-Arm Pre-Post Study 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Gangadevi BAMS 
Designation  Chief Medical Officer 
Affiliation  Sri Sarada Ayurveda Clinic 
Address  Sri Sarada Ayurveda Clinic, First floor, Megawin Towers, E-29, 2nd Ave, GOCHS Colony, Besant Nagar, Chennai, Tamil Nadu 600090

Chennai
TAMIL NADU
600090
India 
Phone  9361052618  
Fax    
Email  dr.gangadevi95@gmail.com   
 
Details of Contact Person
Scientific Query
 
Name  Dr Gangadevi BAMS 
Designation  Chief Medical Officer 
Affiliation  Sri Sarada Ayurveda Clinic 
Address  Sri Sarada Ayurveda Clinic, First floor, Megawin Towers, E-29, 2nd Ave, GOCHS Colony, Besant Nagar, Chennai, Tamil Nadu 600090


TAMIL NADU
600090
India 
Phone  9361052618  
Fax    
Email  dr.gangadevi95@gmail.com   
 
Details of Contact Person
Public Query
 
Name  Dr Gangadevi BAMS 
Designation  Chief Medical Officer 
Affiliation  Sri Sarada Ayurveda Clinic 
Address  Sri Sarada Ayurveda Clinic, First floor, Megawin Towers, E-29, 2nd Ave, GOCHS Colony, Besant Nagar, Chennai, Tamil Nadu 600090


TAMIL NADU
600090
India 
Phone  9361052618  
Fax    
Email  dr.gangadevi95@gmail.com   
 
Source of Monetary or Material Support  
AYUR.AI PRIVATE LIMITED, Villa 2, Abhimanyu Homes, Kanathur, Chennai, 603112 
 
Primary Sponsor  
Name  AYUR.AI PRIVATE LIMITED 
Address  Villa 2, Abhimanyu Homes, Kanathur, Chennai, 603112 
Type of Sponsor  Other [Private company ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Gangadevi   Sri Sarada Ayurveda Clinic  Sri Sarada Ayurveda Clinic, Room No.1, Clinical research division, General medicine department, First floor, Megawin Towers, E-29, 2nd Ave, GOCHS Colony, Besant Nagar, Chennai, Tamil Nadu 600090
Chennai
TAMIL NADU 
9361052618

dr.gangadevi95@gmail.com  
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Dr RK Diabetic Foot and Podiatry Institute & Rakesh Jhunjhunwala Amputation Prevention Center Institutional Ethics Committee (RKDF-IEC)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Gastric Wellness Metabolic Wellness Women’s Wellness  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Sukumaram kashayam, Reference: Ashtangahridayam, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 15(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 6 Months, anupAna/sahapAna: No, Additional Information: -
(2) Medicine Name: Saptasaram kashayam, Reference: Sahasrayogam, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 15(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 6 Months, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  55.00 Year(s)
Gender  Both 
Details  Participants must meet the following general criteria before stratification:
1. Adults aged 25–55 years, of any gender
2. Active smartphone users
3. Presence of non-severe, non-life-threatening health concerns related to gastric, metabolic, or women’s wellness.
4. Willingness to follow the prescribed Whole-System Medicine (WSM) protocol, including dietary, lifestyle, and mind-body interventions.
5. Ability to provide informed consent and comply with study procedures.
6. No surgical procedures or hospital admissions in the last six months
7. No regular use of prescription medications, over-the-counter drugs, or supplements within 2 weeks prior to screening
 
 
ExclusionCriteria 
Details  Participants will be excluded if they meet any of the following:
1. Who do not fall under the set cutoffs of Gastric, Metabolic, Women’s Wellness Group
2. Diagnosis of severe acute or chronic illness requiring urgent or intensive medical care.
3. Pregnant or breastfeeding women.
4. Use of immunosuppressive therapy or active malignancies.
5. History of major psychiatric disorders that may affect adherence to the intervention.
6. Participation in another clinical study within the past three months.
7. Patients with prediabetes, diabetes.
8. History of substance abuse (e.g., alcohol, tobacco, recreational drugs)
9. Occurrence of myocardial infarction, stroke, or angina within the last 3 months prior to enrolment.
10. Individuals with major diagnosed psychiatric disorders (e.g., depression, schizophrenia).
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Multi Dimensional Gastrointestinal Symptom Severity Index
Waist circumference BMI
Womens Health Questionnaire  
Before and after treatment  
 
Secondary Outcome  
Outcome  TimePoints 
Complete Blood Count (CBC), Urine Routine
Bilirubin, SGOP, SGPT, LFT, Serum amylase, lipase, lipid profile
Gut Microbiota Composition
Complete Blood Count (CBC), Urine Routine
Fasting & Postprandial (PP) Glucose, HbA1c, Fasting Insulin, Glycated Albumin
HDL Cholesterol, LDL Cholesterol, Triglycerides
hs-CRP
Homocysteine, apolipoproteins
Renal Profile, Uric Acid
TFT
Complete Blood Count (CBC), Urine Routine
Prolactin, Progesterone, Estradiol, FSH, LH, DHEA-s, Testosterone, T3, T4, TSH
Fasting Glucose, Fasting Insulin, lipid profile
Ferritin & Serum Iron
Vitamin D (25-Hydroxyvitamin D)
 
Before and after treatment  
 
Target Sample Size   Total Sample Size="171"
Sample Size from India="171" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   24/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The increasing prevalence of chronic and lifestyle-related health conditions has highlighted the need for a comprehensive, patient-centred approach to well-being. Conventional medicine often addresses diseases in isolation, focusing on symptom management rather than holistic health optimization. Whole-System Medicine (WSM) is an integrative approach that considers multiple physiological, psychological, and lifestyle factors to improve overall health outcomes. This study aims to evaluate the effectiveness of a WSM-based intervention on well-being through a structured, stratified wellness protocol.

 

Research Question: Can a Whole-System Medicine approach, tailored to individual wellness needs (gastric, metabolic, and women’s wellness), improve health outcomes as measured by symptom-based assessments, biomarkers and gut microbiome composition?

 

Justification for the Study:

There is a growing body of evidence suggesting that whole-system, integrative interventions encompassing nutrition, lifestyle modifications, personalized supplementation, and mind-body practices, can significantly improve health outcomes across various wellness domains. However, most existing research focuses on isolated interventions rather than a holistic, system-based methodology.

This study seeks to address this gap by providing robust evidence on the impact of a Whole-System Medicine approach using a single-arm pre-post design, assessing outcomes through symptoms, biomarkers and gut microbiome composition. By stratifying participants based on wellness needs, this study aims to offer targeted yet holistic interventions that align with personalized health optimization.

 
Close